WebJun 27, 2003 · Chuanbin Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already … WebEDITOR-IN-CHIEF. Robert O. Williams III, University of Texas at Austin, Austin, TX, USA. Editors. Sanyog Jain, NIPER, India Mike Repka, University of Mississippi, USA Claudio Salomon, Universidad Nacional de Rosario, Argentina Daniel Davis, University of Texas at Austin; Social Media Editor Chuanbin Wu, Sun Yat-Sen University, China Tony Zhou, …
Moisture resistant and biofriendly CD-MOF nanoparticles obtained
WebChuanbin Wu Enveloped viruses such as SARS-CoV-2 frequently have a highly infectious nature and are considered effective natural delivery systems exhibiting high efficiency … WebChuanbin Wu, Vice-Dean and Professor in Pharmaceutics, and the head of Guangdong Provincial Research Center of Drug Delivery (GPRCDD). Dr. Wu also services as the … i prof boite mail
Chuanbin Wu Inventions, Patents and Patent Applications - Justia
WebAug 3, 2024 · The low oxygen level in tumors significantly reduces the antitumor efficacy of photodynamic therapy (PDT). The provision of O 2 and monomeric hydrophobic photosensitizers (PSs) under physiological conditions would greatly help to shrink malignant tumors. We take advantage of the high porosity and multifunctionality of metal–organic … WebMay 1, 2016 · E-mail addresses: [email protected] (Xin Pan), [email protected] (Chuanbin Wu). Peer review under responsibility of Institute of Materia Medica, Chinese Academy of Medical Sciences … WebDec 6, 2024 · Chuanbin Wu. Jinan University. Xin Pan. Sun Yat-sen University (SYSU) - School of Pharmaceutical Sciences. Abstract. Cisplatin (DDP)-based ferroptosis-apoptosis synergetic therapy is a novel strategy of lung cancer treatment based on the targeted induction of high oxidative stress levels in tumor cells. Nevertheless, the strong … i prof cm1